Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
2(29%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_2
4
57%
Ph phase_4
1
14%
Ph not_applicable
2
29%

Phase Distribution

0

Early Stage

4

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
4(57.1%)
Phase 4Post-market surveillance
1(14.3%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

80.0%

4 of 5 finished

Non-Completion Rate

20.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

7

all time

Status Distribution
Active(2)
Completed(4)
Terminated(1)

Detailed Status

Completed4
Recruiting2
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (57.1%)
Phase 41 (14.3%)
N/A2 (28.6%)

Trials by Status

withdrawn114%
completed457%
recruiting229%

Recent Activity

Clinical Trials (7)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
7